Parallax Volatility Advisers
CEROW

Parallax Volatility Advisers’s CERo Therapeutics Warrants CEROW Stock Holding History

Parallax Volatility Advisers’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,502
Closed -$399 – 2457
2023
Q4 		$399 Sell
14,502
-5,498
-27% -$172 ﹤0.01% 2104
2023
Q3 		$1.43K Sell
20,000
-80,000
-80% -$5.72K ﹤0.01% 2196
2023
Q2 		$6.54K Sell
100,000
-13,996
-12% -$607 ﹤0.01% 2209
2023
Q1 		$4.57K Sell
113,996
-800
-0.7% -$36 ﹤0.01% 2490
2022
Q4 		$4.95K Hold
114,796
– – ﹤0.01% 2635
2022
Q3 		$9K Sell
114,796
-500
-0.4% -$42 ﹤0.01% 2837
2022
Q2 		$12K Hold
115,296
– – ﹤0.01% 2647
2022
Q1 		$25K Buy
+115,296
New +$42.8K ﹤0.01% 2571

Other funds holding CEROW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

Parallax Volatility Advisers's CEROW Position: Q1 2024 in Review

Parallax Volatility Advisers sold out of CERo Therapeutics Warrants (CEROW) in Q1 2024, closing a stake of 14,502 shares — an estimated $399 sold.

Parallax Volatility Advisers first reported a position in CEROW in Q1 2022 and held it in 8 quarters. The position peaked at $25K in Q1 2022. 37 funds tracked by Wall St. Rank hold CEROW as of Q1 2024.

  • Parallax Volatility Advisers reported no remaining CERo Therapeutics Warrants position as of Q1 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 14,502 CERo Therapeutics Warrants shares in Q1 2024, an estimated $399.
  • Parallax Volatility Advisers first reported a position in CERo Therapeutics Warrants in Q1 2022 and held it in 8 quarters.
  • Parallax Volatility Advisers's CERo Therapeutics Warrants position peaked at $25K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q1 2024.

Based on Parallax Volatility Advisers's 13F filing for Q1 2024, filed 15 May 2024.